DK3595667T3 - Farmaceutiske sammensætninger omfattende en jak-hæmmer - Google Patents
Farmaceutiske sammensætninger omfattende en jak-hæmmer Download PDFInfo
- Publication number
- DK3595667T3 DK3595667T3 DK18713553.8T DK18713553T DK3595667T3 DK 3595667 T3 DK3595667 T3 DK 3595667T3 DK 18713553 T DK18713553 T DK 18713553T DK 3595667 T3 DK3595667 T3 DK 3595667T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- jak inhibitor
- jak
- inhibitor
- pharmaceutical
- Prior art date
Links
- 229940122245 Janus kinase inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762471171P | 2017-03-14 | 2017-03-14 | |
| US201762536614P | 2017-07-25 | 2017-07-25 | |
| PCT/US2018/022027 WO2018169875A1 (en) | 2017-03-14 | 2018-03-12 | Pharmaceutical compositions comprising a jak inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3595667T3 true DK3595667T3 (da) | 2024-01-15 |
Family
ID=61768547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18713553.8T DK3595667T3 (da) | 2017-03-14 | 2018-03-12 | Farmaceutiske sammensætninger omfattende en jak-hæmmer |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20180263997A1 (da) |
| EP (2) | EP3595667B1 (da) |
| JP (2) | JP6979080B2 (da) |
| KR (2) | KR102425226B1 (da) |
| CN (2) | CN110418644A (da) |
| AU (2) | AU2018236156A1 (da) |
| BR (1) | BR102018004952A2 (da) |
| CA (1) | CA3055955C (da) |
| DK (1) | DK3595667T3 (da) |
| FI (1) | FI3595667T3 (da) |
| HR (1) | HRP20240112T1 (da) |
| JO (1) | JOP20180018A1 (da) |
| LT (1) | LT3595667T (da) |
| PL (1) | PL3595667T3 (da) |
| PT (1) | PT3595667T (da) |
| RS (1) | RS65118B1 (da) |
| SI (1) | SI3595667T1 (da) |
| TW (1) | TWI670270B (da) |
| UY (1) | UY37632A (da) |
| WO (1) | WO2018169875A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201808575D0 (en) * | 2018-05-24 | 2018-07-11 | Galapagos Nv | Methods for the treatment of psoriatic arthrits |
| EP3904356A4 (en) * | 2018-12-24 | 2022-09-21 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | THERAPEUTIC USE OF PYRROLOPYRIMIDINE COMPOUND, AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND |
| WO2020177705A1 (zh) * | 2019-03-05 | 2020-09-10 | 苏州科睿思制药有限公司 | Filgotinib的马来酸盐晶型CSI及其制备方法和用途 |
| WO2021044327A1 (en) * | 2019-09-03 | 2021-03-11 | Dr. Reddy's Laboratories Limited | Solid forms of filgotinib maleate and processes thereof |
| CN111672456A (zh) * | 2020-06-18 | 2020-09-18 | 贵州大学 | 一种新型球-棒结构的介孔Janus纳米粒子及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI462920B (zh) * | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| GB201402071D0 (en) * | 2014-02-07 | 2014-03-26 | Galapagos Nv | Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201402070D0 (en) * | 2014-02-07 | 2014-03-26 | Galapagos Nv | Pharmaceutical compositions for the treatment of inflammatory disorders |
| WO2017012770A1 (en) * | 2015-07-23 | 2017-01-26 | Ratiopharm Gmbh | Acid addition salts of filgotinib |
-
2017
- 2017-03-14 JO JOP/2018/0018A patent/JOP20180018A1/ar unknown
-
2018
- 2018-03-12 LT LTEPPCT/US2018/022027T patent/LT3595667T/lt unknown
- 2018-03-12 EP EP18713553.8A patent/EP3595667B1/en active Active
- 2018-03-12 AU AU2018236156A patent/AU2018236156A1/en not_active Abandoned
- 2018-03-12 DK DK18713553.8T patent/DK3595667T3/da active
- 2018-03-12 HR HRP20240112TT patent/HRP20240112T1/hr unknown
- 2018-03-12 KR KR1020217029180A patent/KR102425226B1/ko active IP Right Grant
- 2018-03-12 US US15/918,765 patent/US20180263997A1/en not_active Abandoned
- 2018-03-12 PL PL18713553.8T patent/PL3595667T3/pl unknown
- 2018-03-12 FI FIEP18713553.8T patent/FI3595667T3/fi active
- 2018-03-12 RS RS20240079A patent/RS65118B1/sr unknown
- 2018-03-12 CN CN201880018328.2A patent/CN110418644A/zh active Pending
- 2018-03-12 SI SI201831050T patent/SI3595667T1/sl unknown
- 2018-03-12 CA CA3055955A patent/CA3055955C/en active Active
- 2018-03-12 EP EP23208646.2A patent/EP4368173A2/en active Pending
- 2018-03-12 CN CN202310082905.7A patent/CN116059211A/zh active Pending
- 2018-03-12 WO PCT/US2018/022027 patent/WO2018169875A1/en active Application Filing
- 2018-03-12 JP JP2019550213A patent/JP6979080B2/ja active Active
- 2018-03-12 PT PT187135538T patent/PT3595667T/pt unknown
- 2018-03-12 KR KR1020197029508A patent/KR102303052B1/ko active IP Right Grant
- 2018-03-13 TW TW107108404A patent/TWI670270B/zh active
- 2018-03-13 BR BR102018004952A patent/BR102018004952A2/pt active Search and Examination
- 2018-03-14 UY UY0001037632A patent/UY37632A/es not_active Application Discontinuation
-
2021
- 2021-01-15 AU AU2021200229A patent/AU2021200229B2/en active Active
- 2021-02-26 US US17/186,446 patent/US11975008B2/en active Active
- 2021-09-16 JP JP2021150706A patent/JP2022003053A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR102018004952A2 (pt) | 2018-10-30 |
| KR102303052B1 (ko) | 2021-09-23 |
| CN110418644A (zh) | 2019-11-05 |
| AU2021200229A1 (en) | 2021-03-18 |
| JP2022003053A (ja) | 2022-01-11 |
| JOP20180018A1 (ar) | 2019-01-30 |
| KR20210117345A (ko) | 2021-09-28 |
| EP4368173A2 (en) | 2024-05-15 |
| JP2020510057A (ja) | 2020-04-02 |
| CN116059211A (zh) | 2023-05-05 |
| EP3595667B1 (en) | 2023-12-20 |
| UY37632A (es) | 2018-04-30 |
| KR102425226B1 (ko) | 2022-07-27 |
| LT3595667T (lt) | 2024-01-25 |
| US20180263997A1 (en) | 2018-09-20 |
| RS65118B1 (sr) | 2024-02-29 |
| HRP20240112T1 (hr) | 2024-04-12 |
| TW201837038A (zh) | 2018-10-16 |
| US11975008B2 (en) | 2024-05-07 |
| AU2021200229B2 (en) | 2022-07-07 |
| CA3055955A1 (en) | 2018-09-20 |
| CA3055955C (en) | 2023-03-28 |
| US20210353634A1 (en) | 2021-11-18 |
| WO2018169875A1 (en) | 2018-09-20 |
| AU2018236156A1 (en) | 2019-09-19 |
| EP3595667A1 (en) | 2020-01-22 |
| FI3595667T3 (fi) | 2024-01-12 |
| PL3595667T3 (pl) | 2024-03-18 |
| PT3595667T (pt) | 2024-02-01 |
| SI3595667T1 (sl) | 2024-03-29 |
| KR20190122827A (ko) | 2019-10-30 |
| TWI670270B (zh) | 2019-09-01 |
| JP6979080B2 (ja) | 2021-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102281667B9 (ko) | 아트로핀 약학 조성물 (atropine pharmaceutical compositions) | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| IT201700103760A1 (it) | Struttura di maschera granfacciale | |
| DK3595667T3 (da) | Farmaceutiske sammensætninger omfattende en jak-hæmmer | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| MA47516A (fr) | Composition pharmaceutique | |
| MA49837A (fr) | Compositions pharmaceutiques | |
| BR112016023299A2 (pt) | Composto tricíclico e inibidor de jak | |
| DK3389633T3 (da) | Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat | |
| DK3286190T3 (da) | Farmaceutiske saltformer af en inhibitor af semicarbazid-sensitiv aminoxidase (ssao) | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| DK3609464T3 (da) | Xanthohumolbaserede sammensætninger | |
| DK3601277T3 (da) | Farmaceutisk formulering | |
| DK3528791T3 (da) | Dispergible sammensætninger | |
| DK3288933T3 (da) | Oxindolforbindelser og farmaceutiske sammensætninger deraf | |
| DK3484875T3 (da) | Pyrazolylaminobenzimidazolderivater som JAK-hæmmere | |
| DK3256138T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam | |
| DK3288967T3 (da) | Farmaceutisk forbindelse | |
| DK3908321T3 (da) | Farmaceutisk sammensætning | |
| MA49625A (fr) | Compositions pharmaceutiques | |
| FI20165395A (fi) | Substituoitua bentsofurokinolitsiiniä ja psykoaktiivista lääkettä käsittävät koostumukset | |
| DK3218060T3 (da) | Spraybare analgetiske sammensætninger | |
| DK2974721T3 (da) | En farmaceutisk sammensætning omfattende et gasgenererende ingrediens |